Expert Opin Drug Saf. 2012 Sep;11(5):685-8. doi: 10.1517/14740338.2012.712683. Epub 2012 Aug 6.
The use of antidepressant up-titration in starting therapies is useful in reducing side effects, but can induce delays in clinical response. Several aspects concerning slow or more aggressive titration have to be considered when using this strategy, such as pharmacological aspects (e.g., synaptic up-regulation) and psychological/clinical aspects (e.g., adherence to antidepressant treatment, and the temperament and expectations of patients). Data from the literature are controversial, and so the choice between rapid and slow titration must be tailored more to the patient, rather than to the drug.
在起始治疗中使用抗抑郁药加量是有用的,可以减少副作用,但可能会延迟临床反应。在使用这种策略时,需要考虑到缓慢或更激进的加量的几个方面,如药理学方面(例如,突触上调)和心理/临床方面(例如,对抗抑郁治疗的依从性,以及患者的气质和期望)。文献中的数据存在争议,因此快速和缓慢加量的选择必须更多地针对患者,而不是针对药物。